New Study in Ocriplasmin for the Treatment of Symptomatic Vitreomacular Adhesion/Traction
(PRWEB UK) 3 June 2015 — Recent advancements in imaging technology have allowed a more in-depth understanding of the diseases of the vitreoretinal interface (VRI), and have also changed how we evaluate the effectiveness of different treatment options.